Article Details

ASH: AbbVie, Roche's fixed-duration Venclexta combos gain steam in CLL

Retrieved on: 2020-12-05 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

ASH: AbbVie, Roche's fixed-duration Venclexta combos gain steam in CLL. View article details on hiswai:

Excerpt

“Now, we <b>see</b> with five years of follow-up that fixed duration administration indeed is not just high remission rates, but durable and long-lasting.” Read ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up